Superior Activity of Fusion Protein scFvRit:sFasL Over Cotreatment With Rituximab and Fas Agonists
Cancer Research - United States
doi 10.1158/0008-5472.can-07-5171
Full Text
Open PDFAbstract
Available in full text
Date
January 15, 2008
Authors
Publisher
American Association for Cancer Research (AACR)